• The Cost of Chronic Myeloid Leukemia Therapy, Financial Toxicity, and the Mark Cuban Effect

  • Jun 29 2023
  • Length: 24 mins
  • Podcast

The Cost of Chronic Myeloid Leukemia Therapy, Financial Toxicity, and the Mark Cuban Effect

Listen for free

View show details

  • Summary

  • Drs Michael J. Mauro and Hagop Kantarjian discuss the cost of chronic myeloid leukemia therapy, long-term safety, adverse events, and the financial toxicity to the patient and the healthcare system.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/989022). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Chronic Myelogenous Leukemia (CML) https://emedicine.medscape.com/article/199425-overview

    Influence of the 'Mark Cuban Effect' on Cancer Drug Prices in the United States: Focus on CML https://ascopost.com/issues/february-10-2023/influence-of-the-mark-cuban-effect-on-cancer-drug-prices-in-the-united-states-focus-on-cml/

    Response and Resistance to BCR-ABL1-targeted Therapies https://pubmed.ncbi.nlm.nih.gov/32289275/

    Imatinib (Rx) https://reference.medscape.com/drug/gleevec-imatinib-342239

    Tyrosine Kinase Inhibitors https://www.ncbi.nlm.nih.gov/books/NBK563322/

    National Cancer Institute Surveillance, Epidemiology, and End Results Program (SEER). Cancer Stat Facts: Leukemia — Chronic Myeloid Leukemia (CML) https://seer.cancer.gov/statfacts/html/cmyl.html

    Management of Chronic Myeloid Leukemia in 2023 - Common Ground and Common Sense https://pubmed.ncbi.nlm.nih.gov/37088793/

    Assessment of Imatinib as First-line Treatment of Chronic Myeloid Leukemia: 10-year Survival Results of the Randomized CML Study IV and Impact of Non-CML Determinants https://pubmed.ncbi.nlm.nih.gov/28804124/

    Toxicities of Receptor Tyrosine Kinase Inhibitors in Cancer Pharmacotherapy: Management With Clinical Pharmacology https://pubmed.ncbi.nlm.nih.gov/28059038/

    Dasatinib (Rx) https://reference.medscape.com/drug/sprycel-dasatinib-342199

    Nilotinib (Rx) https://reference.medscape.com/drug/tasigna-nilotinib-342198

    Ponatinib (Rx) https://reference.medscape.com/drug/iclusig-ponatinib-999800

    Asciminib https://reference.medscape.com/drug/scemblix-asciminib-4000255

    Treatment-free Remission: The New Goal in CML Therapy https://pubmed.ncbi.nlm.nih.gov/34618317/

    Monitoring Molecular Response in Chronic Myeloid Leukemia https://pubmed.ncbi.nlm.nih.gov/20960522/

    Cost Plus Drugs https://costplusdrugs.com/

    U.S. Health Care From a Global Perspective, 2022: Accelerating Spending, Worsening Outcomes https://www.commonwealthfund.org/publications/issue-briefs/2023/jan/us-health-care-global-perspective-2022
    Show More Show Less
Show More Show Less
activate_samplebutton_t1

What listeners say about The Cost of Chronic Myeloid Leukemia Therapy, Financial Toxicity, and the Mark Cuban Effect

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com.au reviews

Amazon Reviews
No Reviews are Available
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.